Warning: The NCBI web site requires JavaScript to function. more...
Gene-expression patterns reveal underlying biological processes in Kawasaki disease.
Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, Brown PO, Burns JC, Relman DA.
Genome Biol. 2007;8(12):R261.
Related citations
Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
Fury W, Tremoulet AH, Watson VE, Best BM, Shimizu C, Hamilton J, Kanegaye JT, Wei Y, Kao C, Mellis S, Lin C, Burns JC.
Hum Immunol. 2010 Sep;71(9):865-73. Epub 2010 Jun 20.
Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
Abe J, Ebata R, Jibiki T, Yasukawa K, Saito H, Terai M.
J Allergy Clin Immunol. 2008 Nov;122(5):1008-1013.e8. Epub 2008 Oct 19.
[Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
Zhonghua Er Ke Za Zhi. 2004 Sep;42(9):688-92. Chinese.
Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease.
Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M.
J Immunol. 2005 May 1;174(9):5837-45.
Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection.
Popper SJ, Watson VE, Shimizu C, Kanegaye JT, Burns JC, Relman DA.
J Infect Dis. 2009 Aug 15;200(4):657-66.
Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment.
Schiller B, Elinder G.
Acta Paediatr. 1999 Aug;88(8):844-8.
Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy.
Olivito B, Taddio A, Simonini G, Massai C, Ciullini S, Gambineri E, de Martino M, Azzari C, Cimaz R.
Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):93-7.
Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study.
Nomura I, Abe J, Noma S, Saito H, Gao B, Wheeler G, Leung DY.
Pediatr Res. 2005 Jan;57(1):49-55. Epub 2004 Nov 5.
Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.
Kobayashi T, Kimura H, Okada Y, Inoue Y, Kobayashi T, Shinohara M, Morikawa A.
Clin Exp Immunol. 2007 Apr;148(1):112-8.
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM, Silverman ED, McCrindle BW, Yeung RS.
J Pediatr. 2002 Apr;140(4):450-5.
[Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW, Wang DW, Li J, Qin YM, Wang FM, Cao LM, Zhang LF, Hu Z.
Zhonghua Er Ke Za Zhi. 2005 Aug;43(8):612-5. Chinese.
Soluble forms of P-, E- and L-selectin in children with Kawasaki disease.
Furui J.
Kurume Med J. 2001;48(2):135-43.
Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R.
J Clin Immunol. 2001 May;21(3):193-9.
Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.
Ikeda K, Yamaguchi K, Tanaka T, Mizuno Y, Hijikata A, Ohara O, Takada H, Kusuhara K, Hara T.
Clin Exp Immunol. 2010 May;160(2):246-55. Epub 2009 Dec 15.
High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease.
Lee KY, Lee HS, Hong JH, Han JW, Lee JS, Whang KT.
J Trop Pediatr. 2005 Apr;51(2):98-101. Epub 2005 Jan 26.
Oligoclonal IgA response in the vascular wall in acute Kawasaki disease.
Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC.
J Immunol. 2001 Jan 15;166(2):1334-43.
Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
Ichiyama T, Ueno Y, Hasegawa M, Ishikawa Y, Matsubara T, Furukawa S.
Rheumatology (Oxford). 2005 Mar;44(3):314-7. Epub 2004 Nov 30. Erratum in: Rheumatology (Oxford). 2005 Apr;44(4):569.
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics. 2004 Dec;114(6):e689-93. Epub 2004 Nov 15.
Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I.
Clin Immunol. 2002 May;103(2):161-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on